Prednisone (generic), Deltasone, Orasone News

By DAYNA WORCHEL Staff Writer A neuropharmacologist testified Tuesday that a drug commonly prescribed for some autoimmune conditions can cause psychiatric problems, even in someone who does not have a history of such problems.

QUINCY, Ill. - During his first two years at Quincy University, Luke Weaver became a familiar figure to many of his fellow students.

Cabazitaxel has been approved since March 2011 in men with metastatic prostate cancer who no longer respond to conventional therapy with hormone blockers and have already been pre-treated with the cytostatic drug docetaxel.

Jonas H Graversen 1 , Pia Svendsen 1 , 2 , Frederik Dagnæs-Hansen 2 , Jakob Dal 2 , Gabriele Anton 1 , Anders Etzerodt 2 , Mikkel D Petersen 2 , Peter A Christensen 1 , 3 , Holger J Møller 3 and Søren K Moestrup 2 , 3 Correspondence: Søren K Moestrup, Department of Biomedicine, Aarhus University, Ole Worms Alle 3, ... (more)

During his first two years at Quincy University, Luke Weaver became a familiar figure to many of his fellow students.

Coping with lupus. Jess Guyon overcame a life-threatening lupus attack in 2009 to have two of her original plays staged at the Halton Sears Drama Festival.

While early-stage cancers can be monitored, but not necessarily acted on, advanced versions often require an invasive procedure, either through surgery or radiation.

Men with prostate cancer could significantly benefit from a recently approved hormone-depleting drug, according to results from a phase II clinical trial.

There has always been a large focus on testing new treatments for cancer and disease, but a new study on Idiopathic pulmonary fibrosis sheds light on the importance of testing standard treatment, as it could present fatal risks as well.

Alternative Health Arthritis Asthma & Allergies Autism Breast Cancer Cancer Cardiovascular Health Children's Health Dental Health Diabetes Fertility & Pregnancy Men's Health Mental Health Multiple Sclerosis Neurological Disorders Nutrition & Wellness Orthopedics Pet Health Robotics Seniors' Health Sports Medicine Vision Women's Health - There has ... (more)

Jassen Research & Development, LLC Release: ZYTIGAA Data to be Presented at 2012 American Society of Clinical Oncology Annual Meeting /PRNewswire/ -- Data related to ZYTIGAA clinical studies have been selected for presentation at the 48th Annual Meeting of the American Society of Clinical Oncology .

A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, according to a clinical study to be presented at the annual meeting of the American Society of Clinical Oncology , June 1-5, ... (more)

Additionally, data regarding the investigational compounds ibrutinib and siltuximab also have been accepted for presentation.

Mary-Ellen Taplin, M.D., of Dana-Farber Cancer Institute, and colleagues have demonstrated that a hormone-depleting drug approved for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors... BOSTON--A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or ... (more)

Q: I was a nanny last summer, and one day we were in the kids' backyard. Their dog knocked a yellow jacket down, but it was still alive.

The Yankees first baseman visited a chest specialist at Columbia Presbyterian yesterday and was diagnosed with "severely inflamed bronchial airways" that have impacted his breathing.

New England Journal of Medicine Reports on Three Phase III REVLIMIDA Trials in Patients with Newly Diagnosed Multiple Myeloma Celgene International SA rl, a subsidiary of Celgene Corporation , today announced that results from three phase III studies evaluating the use of continuous REVLIMID A treatment in newly diagnosed multiple myeloma patients ... (more)

The last time your doctor gave you a prescription, it likely came with specific information on the correct and safe dosage to take, determined from years of clinical trials.

DEAR DR. DONOHUE: Please do an article on ulcerative colitis. My grandson, 17, has been diagnosed with it.

Researchers analyzing Medicaid data on approximately 8,500 children with juvenile idiopathic arthritis and more than 360,000 children without arthritis found that children with juvenile idiopathic arthritis have higher rates of bacterial infections during hospitalization.1 High-dose steroids were associated with a higher risk for infection and ... (more)